Vectura Share Discussion Threads

[diesel] 01/6/2017 17:23

Not sure about protectionism, it is Glaxo after all, as for SP, we have had little good news since the merger, doesn't do much for market confidence, so not surprised really, I have sold some at around 150p now wish I'd sold out!

[carpadium] 01/6/2017 17:11

To think VEC would now be 170 - 180, maybe 190 had the FDA decision been in favour.
Just shows the risk company and shareholders run with new product acceptance. Bad enough to fail on the actual product falling short on expectations but to fall victim to protectionism, to which America squeals loudest when on the receiving end, makes me query is it worth the time trouble and expense in attempting to get FDA approval. Their decision has bombed Vectura for some time yet and I pin little faith in a turnaround any time soon.
The product pipeline looks great 2020-2025, but in the next couple of years, wanting. Great if you've years ahead to tuck this one away, it will recover in time and possibly gain approval for Advair second time round, maybe even get taken over but, as I'm in my seventies, it's the wrong stock for me. Fortunately reduced holding at a far better price than we're seeing now, will lock away the balance and just hope I'm around for any recovery. GL to all.

[a0148009] 01/6/2017 12:59

Lumpy seller very busy getting close to 114 my first stop.

[dstorey1] 01/6/2017 12:47

Merely Market at work. You buy, you sell. Personally a sign that trend down is in final stage(s).

[az4hr] 01/6/2017 12:35

this is brutal

[fhmktg] 01/6/2017 11:40

Alex, September and the trading update....enjoy the summer and keep the faith!

[dstorey1] 01/6/2017 10:21

Alex I bought in at 121 and I considered that a good buy based purely on technicals. At these levels they are even more so and getting tempted to top up. No advice intended.

[alexchry] 01/6/2017 10:10

dstorey1-Unfortunately, you were right, it can go lower. We need some good news to stop the rot, not sure where it will come from, though.

[dstorey1] 31/5/2017 16:07

So am I:) Could be on a rebound soon.

[alexchry] 31/5/2017 15:32

dstorey1-hope you're wrong, just bought back most of the 10k that I sold for 148 recently.

[stockrod43] 26/5/2017 19:07

can it go any lower?

[richtea1701] 26/5/2017 16:39

Thank you Dontay - interesting company

[dontay] 26/5/2017 14:31

Richtea... have look at air partner (air) share price around 120p, main exchange, cash generating machine, around 4.5% dividend yield, well run, great long term growth prospects, very laid back even UNexciting narrative from the BOD. Just very recently gone through a 5 for 1 share split... was £5 went to £1 on the split now around 120/125p.

[richtea1701] 26/5/2017 10:57

Sound posts from those attending AGM. Been a test of my investing resolve these last few months but I'm holding until the story changes. What other shares are holders excited by. Got a bit on the sidelines but can't justify anymore of these, sadly:

[gbcol] 26/5/2017 10:21

Fortunately bought lots when SKP was near lows, so still showing a profit albeit that has seen a massive reduction since the merger completed.

I didn't expect to be adding to my overweight position but since the falls I have bought more at 129p, 121p and again this morning at 118p. It's going to take a while to get back to where I was hoping to be at this point (closer to 180-200p) but I'm confident we will get there and beyond in the medium term.

I may live to regret this comment but most of the downside risk should be priced in now although not sure there will be significant positive news in the short term. Hopefully the board will do what they said and work on getting their positive pipeline message out there and continue on the business development which they talked so confidently about.

[a0148009] 26/5/2017 10:01

Likewise a long term holder and managed to recover paper losses on SKN with profits on VEC soon after the bid,on balance now under water again.You have to be a bit of a masochist to survive in developing Pharma companies.I wonder if USA will be buyers down at this level.

[gbcol] 26/5/2017 09:33

I wouldn't personally expect any bounce directly from the AGM as there was only a handful of people there and the information was generally all already basically in the public domain. The confidence expressed by the board will only have any impact as and when they can communicate that more widely (which they seem intent on doing) or produce concrete results from the pipeline. However, for those that were there (well for me anyway) it underlined my views that this great potential will eventually come to fruition. Just need a bit more patience but as I have been in SKP/VEC for over 15 years I am used to that!

[a0148009] 26/5/2017 09:08

I expected a bounce in the share price this morning closing shorts but nothing so far possible seller still unloading? Looking at the chart current price appears to be a level of resistance. AGM has not made any impact so far which is disappointing from the confident comment made above.

[gbcol] 26/5/2017 07:50

I agree with Alex, it was a positive presentation. My main takeaway was that the board are very confident in the future and pleased with progress being made (despite some disappointments).

They do not think that the market has priced in the substantial pipeline and they plan to address this.

I have a substantial holding (ex SKP) and am very frustrated by the poor share price performance but I think the medium/ long term share price growth should be substantial. I am not going to be selling anytime soon, in fact despite being very overweight here, at current share price levels, I will be adding when funds allow - NIA, DYOR etc etc

[popper joe] 25/5/2017 22:17

alex2727, I wonder if you could clarify a point that you made in your earlier post summarising the AGM, in which you wrote: "the merger was going to cost £3-5M more than expected." I have just looked at the presentation from the AGM and I see that the slide on "Financial Outlook and Capital Allocation" has a line that states: "Further merger-related exceptional costs £3m – £5m expected."

Was it specifically stated at the meeting that this was an additional £3m to £5m above and beyond what was originally expected? Or is it the case that of the planned merger costs that were identified at the start, some has already been spent and a further £3m to £5m is still to be spent?

[cap160] 25/5/2017 17:52

Thanks for the update alex2727--re assuring.

[carpadium] 25/5/2017 17:25

Cheers alex2727, great to hear from someone who has talked face to face with board members. Thanks for the feedback. One more question if you don't mind, was there any mention re. reaction to Sunovion's initial Utibron sales efforts in the US?...if not, and possibly too soon, we'll no doubt be updated on June 28th.

[alex2727] 25/5/2017 16:53

Revenues for the last nine months £126M, with high expectations for this year. Flutiform performing very well.

From coffee after with Frank Condella and Andrew Derodra, despite the setback, these were two very confident guys, very much looking forward to the next year. The FDA process was discussed at some length and they certainly weren't phased by what had to be done.